1,200 articles
Manuel Hidalgo (oncologist)
Manuel Hidalgo, full name Manuel Hidalgo Medina, is a Spanish-trained medical oncologist known for pancreatic cancer drug development, pioneering patient-derived xenograft "avatar" mouse models, and advancing nab-paclitaxel.
Manuel Perucho
Manuel Perucho is a Spanish cancer biologist known for discovering human ras oncogenes and the microsatellite mutator phenotype, with career work at Cold Spring Harbor, La Jolla, and Barcelona.
Manuel Serrano
Manuel Serrano is a Spanish cancer biologist who discovered the p16 anti-cancer gene in 1993 and performed the first reprogramming of cells within a living organism in 2013.
Marc Buyse
Marc Buyse is a Belgian biostatistician, associate professor at Hasselt University, known for validating surrogate endpoints in cancer trials, generalized pairwise comparisons, and founding IDDI, CluePoints, and One2Treat.
Marcel Kool
Marcel Kool is a pediatric neurooncology and cancer genomics researcher who leads research groups at the Hopp Children's Cancer Center Heidelberg and the Princess Máxima Center in Utrecht.
Marcela V. Maus
Marcela Maus is a physician-scientist who directs the Cellular Immunotherapy Program at Massachusetts General Hospital and develops CAR T cell therapies for solid tumors, especially glioblastoma.
Marcia Haigis
Marcia C. Haigis (마샤 헤이기스) is an American cancer biologist and Harvard Medical School professor known for research on tumor metabolism, anti-tumor immunity, and aging.
Marco Colleoni
Marco Colleoni is an Italian medical oncologist who directs the Division of Medical Senology at the European Institute of Oncology in Milan, specializing in breast cancer.
Marco Marra
Marco A. Marra is a Canadian genome scientist who led the 2003 sequencing of the SARS coronavirus and co-led Canada's Personalized OncoGenomics program for advanced cancer patients.
Margaret A. Shipp
Margaret A. Shipp is an American medical oncologist who leads the Division of Hematologic Neoplasia at Dana-Farber and coordinated the International Prognostic Index for lymphoma.
Margaret A. Tucker
Margaret A. Tucker is an American physician-scientist and genetic epidemiologist who led the National Cancer Institute's familial cancer research for over 40 years, quantifying BRCA1 and BRCA2 cancer risks.
Maria G. Masucci
Maria G. Masucci (Maria Grazia Masucci) is an Italian-trained virologist and Senior Professor at Karolinska Institutet, known for her work on how Epstein-Barr virus evades immunity.
Maria Sibilia
Maria Sibilia is an Austrian cancer biologist who heads the Center for Cancer Research at the Medical University of Vienna and studies how EGFR signaling drives tumor development.
Mariano Provencio
Mariano Provencio Pulla is a Spanish medical oncologist, head of Medical Oncology at Hospital Universitario Puerta de Hierro in Madrid, known for the NADIM lung cancer trials.
Mariella Gruber Filbin
Mariella Gruber Filbin is an Austrian-trained pediatric neuro-oncologist and cancer researcher who studies and treats childhood brain tumors at Dana-Farber Cancer Institute and Boston Children's Hospital.
Marilyn Stovall
Marilyn Stovall is a radiation physicist and epidemiologist who spent 64 years at MD Anderson Cancer Center, known for quantifying second-cancer risk and reconstructing radiation doses for over 100,000 survivors.
Marina Chiara Garassino
Marina Chiara Garassino is an Italian medical oncologist specializing in thoracic cancers, and Professor of Medicine and Director of Thoracic Programs at the University of Chicago, known for leading the KEYNOTE-189 trial.
Mario A. Eisenberger
Mario A. Eisenberger is a medical oncologist and Professor Emeritus at Johns Hopkins whose TAX 327 docetaxel trial established chemotherapy as survival-prolonging treatment for metastatic prostate cancer.
Mario L. Suvà
Mario L. Suvà is a physician-scientist, Vice-Chair of Pathology for Research at Massachusetts General Hospital and Harvard associate professor, known for single-cell studies of glioma cellular states.
Mark A. Socinski
Mark A. Socinski is an American medical oncologist specializing in lung cancer and mesothelioma, and Executive Medical Director of the AdventHealth Cancer Institute in Orlando, Florida.
Mark B. Faries
Mark B. Faries is an American surgical oncologist and melanoma specialist who leads Surgical Oncology at The Angeles Clinic in Los Angeles and led the MSLT-II trial.
Mark Bower
Mark Bower is a British medical oncologist, Professor at Imperial College London and consultant at Chelsea and Westminster Hospital, known for AIDS-related cancer care and a 2006 Kaposi's sarcoma prognostic index.
Mark E. Ewen
Mark E. Ewen is a cancer biologist at Dana-Farber Cancer Institute and Harvard Medical School in Boston whose research concerns cell division control, notably the retinoblastoma protein and cyclin D1.
Mark G. Kris
Mark G. Kris is an American thoracic medical oncologist and emeritus member of Memorial Sloan Kettering, known for clinical trials bringing EGFR-targeted therapy into lung cancer practice.
Mark J. Ratain
Mark J. Ratain, born 1954, is an American oncologist at the University of Chicago known for cancer pharmacogenetics, phase I trial design, and the UGT1A1 work behind the 2005 irinotecan label change.
Mark M. Awad
Mark M. Awad, known professionally as Mark Awad, is a thoracic medical oncologist and chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center in New York.
Mark N. Levine
Mark N. Levine is a Canadian medical oncologist and Professor Emeritus at McMaster University whose trials shortened chemotherapy after breast cancer surgery and reshaped radiotherapy.
Mark Smyth
Mark J. Smyth, born 1963 in Hobart, is an Australian immunologist known for cancer immunosurveillance and NK cell biology, who resigned from QIMR Berghofer in 2021 after misconduct findings.
Markus Müschen
Markus Müschen (Markus Muschen) is a German-born hematologist-oncologist and cancer biologist who directs the Center of Molecular and Cellular Oncology at Yale, studying B-cell signaling and metabolism in leukemia and lymphoma.
Markus Raderer
Markus Raderer is an Austrian oncologist and associate professor at the Medical University of Vienna, known for his research on MALT lymphoma and gastrointestinal tumors.